期刊文献+

人血清IA-2抗体检测方法的建立及应用

下载PDF
导出
摘要 目的建立糖尿病患者血清中IA-2自身抗体的检测方法。方法以原核表达的人IA-2融合蛋白作为抗原建立人血清IA-2抗体的固相酶联免疫吸附检测方法(ELISA),该方法经优化后用于糖尿病患者血清中IA-2抗体的检测。结果该文所建立方法的平均批内和批间变异系数分别为6.8%和7.7%;回收率为99.2%~105%。所测定的1型和2型糖尿病患者血清中IA-2抗体的阳性率分别为49%和3.6%。结论应用原核表达的人IA-2蛋白为抗原所建立的ELISA方法简单且可靠,为糖尿病患者血清中IA-2抗体的检测提供了条件。
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第5期552-553,共2页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市卫生局科技发展基金(00418) 上海高校自然科学研究基金(2000B16)资助项目
  • 相关文献

参考文献6

  • 1Lan MS,Wasserfall C,Maclaren NK,et al.IA-2,a transmembrane protein of the protein tyrosine phosphatase family,is a major autoantigen in insulin-dependent diabetes mellitus[J].Proc Natl Acad Sci USA,1996,93 (13):6367-6370.
  • 2Zhang B,Lan MS,Notkins AL.Autoantibodies to IA-2 in IDDM:location of major antigenic determinants[J].Diabetes,1997,46(1):40 -43.
  • 3贾秀娟,陈战,许光武,谢超,谢晓雁,罗敏.人胰岛素瘤相关蛋白-2基因的克隆及原核表达研究[J].上海第二医科大学学报,2003,23(3):196-199. 被引量:2
  • 4Vogt RF Jr,Phillips DL,Henderson LO,et al.Quantitative differences among various protein as blocking agents for ELISA microtiter plates[J].J Immunol Methods,1987,101 (1):43-50.
  • 5Seissler J,de Sonnaville JJJ,Morgenthaler NG,et al.Immunological heterogeneity in type 1 diabetes:presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease[J].Diabetologia,1998,41 (8):891-897.
  • 6Inukai T,Fujiwara Y,Tayama K,et al.Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase[J].Exp Clin Endocrinol Diabetes,1997,105(6):327 -330.

二级参考文献9

  • 1Bonifacio E, Lampasona V, Bingley PJ. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigen [J]. J Immunol, 1998, 161:2648-2654.
  • 2Masuda M, Powell M, Chen S, et al. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus: measurements with a new immunoprecipitation assay [J]. Clinica Chimica Acta, 2000, 291:53-66.
  • 3Lobner K, Khoo-Morgenthaler UY, Seissler J, et al. Detection of autoantibodies to the diabetes-associated antigen IA-2 by a sensitive enzyme-linked immunosorbent assay [J]. Horm Metab Res, 1999, 31:686-691.
  • 4Balaji M, Shtauvere BA, Balaji V, et al. Women diagnosed with gestational diabetes mellitus do not carry antibodies against minor islet cell antigens [J]. Ann N Y Acad Sci, 2002, 958:281-284.
  • 5Grasso YZ, Reddy SK, Rosenfeld CR, et al. Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: prevalence and correlation with clinical features [J]. Endocr Pract, 2001, 7 (5):339-345.
  • 6Hawkes CJ, Schloot NC, Marks J, et al. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase like autoantigen IA-2 in type 1 diabetes [J]. Diabetes, 2000, 49 (3): 356-366.
  • 7Pastore MR, Balini A, Bazzigaluppi E, et al. Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives [J]. Diabetes Care, 1998, 21: 1445-1450.
  • 8Kolm LV, Berlo S, Bonifacio E, et al. Human monoclonal antibodies isolated from type 1 diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen [J]. J Immunol, 2000, 165 (8):4676-4684.
  • 9Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibodies, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: combinatorial islet autoantibody workshop [J]. Diabetes, 1998, 47: 1857-1866.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部